Stability Comparison of TIVA and Sevoflurane in Prone Spinal Surgery(TIVA:Total Intravenous Anesthesia)
NCT ID: NCT06558695
Last Updated: 2024-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2023-05-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Objective:
o To compare the effects of Total Intravenous Anesthesia (TIVA) and sevoflurane anesthesia on respiratory mechanics, hemodynamic parameters, and neuromonitoring during prone position spinal surgeries.
2. Methodology:
* A randomized controlled trial involving 52 patients scheduled for lumbar spine surgery, randomly assigned to either TIVA or sevoflurane groups.
* Respiratory and hemodynamic parameters were measured at various time points.
3. Results:
* No significant differences were found between the TIVA and sevoflurane groups in terms of respiratory mechanics or hemodynamic stability.
* Both anesthesia techniques maintained stable intraoperative conditions.
4. Clinical Implications:
* Anesthesiologists can flexibly choose between TIVA and sevoflurane based on patient-specific factors and surgical requirements.
* TIVA may be preferred in surgeries with high neurological risk due to its compatibility with neuromonitoring.
5. Future Research:
* Studies with broader patient populations and long-term outcomes are needed to further refine anesthesia management strategies.
* Research on the environmental impact and cost-effectiveness of anesthesia techniques is also important.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of TIVA and Inhalation Anesthesia on Oxidative Stress Factors During Hypotensive Anesthesia
NCT04310748
The Effect of Minimal Flow Anesthesia on Oxidative and Neuroendocrine Stress Response
NCT06611449
Effects of Low-Flow Sevoflurane Anesthesia on Pulmonary Function During One-Lung Ventilation
NCT07085546
TIVA Versus Inhalational Anesthesia and Tissue Oxygenation in Cardiac Surgery
NCT05320341
Evaluation of the Effects of Preoperative Anxiety in Patients Undergoing Total Intravenous Anesthesia (TIVA)
NCT04690764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sevoflurane Group
In the Sevoflurane group, general anesthesia was maintained with sevoflurane at 0.8-1.0 minimum alveolar concentration (MAC).
Sevoflurane
Sevoflurane was managed for maintenance of the general anestesia during spinal surgeries
TIVA group
In the TIVA (Total Intra Venous Anesthesia) group, a combination of propofol (50-150 μg/kg/min) and remifentanil (0.02-0.2 μg/kg/min) was used for general anesthesia instead of inhalational agents.
TIVA
TIVA was managed for maintenance of the general anesthesia during spinal surgeries
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane
Sevoflurane was managed for maintenance of the general anestesia during spinal surgeries
TIVA
TIVA was managed for maintenance of the general anesthesia during spinal surgeries
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Major cardiac conditions, such as recent myocardial infarction or a left ventricular ejection fraction (EF) less than 55%
* Atrioventricular blocks of second and third degrees
* Allergies to any drugs
* Severe neurological disorders
* History of sedative or opioid use
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saglik Bilimleri Universitesi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YÜCEL YÜCE
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yücel Yüce, MD,Assoc Prf
Role: PRINCIPAL_INVESTIGATOR
Saglik Bilimleri Universitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saglik Bilimleri Universitesi
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SaglikBilimleriU-KLKSH-Anes-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.